source
- GSK completes $10.6 billion acquisition of Nuvalent, the largest in its historyGSK announced it has completed a $10.6 billion purchase of Nuvalent, marking the biggest deal the company has ever undertaken. The transaction was disclosed on Tuesday and values Nuvalent at $124…
- Enliven Therapeutics raises $400M as Jazz's Zepzelca misses confirmatory trialEnliven Therapeutics, a biotech based in Burlingame, California, announced that it priced a public offering of its common stock that raised about $400 million. The capital raise follows the compan…